Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Exemestane.
Amiodarone
The metabolism of Exemestane can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Exemestane.
Advertisement
Apalutamide
The serum concentration of Exemestane can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Exemestane can be increased when it is combined with Aprepitant.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Exemestane.
Advertisement
Atazanavir
The metabolism of Exemestane can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Exemestane can be decreased when combined with Atomoxetine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Exemestane.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Exemestane.
Boceprevir
The metabolism of Exemestane can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Exemestane can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Exemestane can be decreased when it is combined with Bosentan.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Exemestane.
Carbamazepine
The serum concentration of Exemestane can be decreased when it is combined with Carbamazepine.
Ceritinib
The serum concentration of Exemestane can be increased when it is combined with Ceritinib.
Chlorotrianisene
The therapeutic efficacy of Exemestane can be decreased when used in combination with Chlorotrianisene.
Clarithromycin
The metabolism of Exemestane can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Exemestane can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Exemestane can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Exemestane can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Exemestane.
Crizotinib
The metabolism of Exemestane can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Exemestane.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Exemestane.
Cyclosporine
The metabolism of Exemestane can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Exemestane can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Exemestane can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Exemestane can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Exemestane can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Exemestane can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Exemestane can be decreased when combined with Delavirdine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Exemestane.
Dienestrol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Dienestrol.
Diethylstilbestrol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Diethylstilbestrol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Exemestane.
Digoxin
Digoxin may decrease the cardiotoxic activities of Exemestane.
Dihydroergotamine
The metabolism of Exemestane can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Exemestane can be decreased when combined with Diltiazem.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Exemestane.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Exemestane.
Doxycycline
The metabolism of Exemestane can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Exemestane can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Exemestane can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Exemestane can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The therapeutic efficacy of Exemestane can be decreased when used in combination with Equol.
Erythromycin
The metabolism of Exemestane can be decreased when combined with Erythromycin.
Estradiol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol.
Estradiol acetate
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol acetate.
Estradiol Cypionate
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol cypionate.
Estradiol Valerate
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol valerate.
Estriol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estriol.
Estrogens, Conjugated (USP)
The therapeutic efficacy of Exemestane can be decreased when used in combination with Conjugated estrogens.
Estrogens, Esterified (USP)
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estrogens, esterified.
Estrone
The therapeutic efficacy of Exemestane can be decreased when used in combination with Estrone.
Ethinyl Estradiol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Ethinyl Estradiol.
Fluconazole
The metabolism of Exemestane can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Exemestane can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Exemestane can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Exemestane can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Exemestane can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Exemestane can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Exemestane can be increased when it is combined with Fusidic Acid.
Genistein
The therapeutic efficacy of Exemestane can be decreased when used in combination with Genistein.
Hypoxis hemerocallidea root extract
The serum concentration of Exemestane can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Exemestane can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Exemestane can be decreased when combined with Imatinib.
Indinavir
The metabolism of Exemestane can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Exemestane can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Exemestane can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Exemestane can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Exemestane can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Exemestane can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Exemestane can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Exemestane can be decreased when combined with Ketoconazole.
Lopinavir
The metabolism of Exemestane can be decreased when combined with Lopinavir.
Lovastatin
The metabolism of Exemestane can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Exemestane can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Exemestane can be decreased when it is combined with Lumacaftor.
Mestranol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Mestranol.
Methadone
The serum concentration of Methadone can be increased when it is combined with Exemestane.
Mifepristone
The serum concentration of Exemestane can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Exemestane can be decreased when it is combined with Mitotane.
Nefazodone
The metabolism of Exemestane can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Exemestane can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Exemestane can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Exemestane can be decreased when it is combined with Nevirapine.
Nilotinib
The metabolism of Exemestane can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Exemestane can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Exemestane can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Exemestane.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Exemestane.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Exemestane.
Palbociclib
The serum concentration of Exemestane can be increased when it is combined with Palbociclib.
Pentobarbital
The serum concentration of Exemestane can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Exemestane can be decreased when it is combined with Phenobarbital.
Phenytoin
The serum concentration of Exemestane can be decreased when it is combined with Phenytoin.
Polyestradiol Phosphate
The therapeutic efficacy of Exemestane can be decreased when used in combination with Polyestradiol phosphate.
Posaconazole
The metabolism of Exemestane can be decreased when combined with Posaconazole.
Primidone
The serum concentration of Exemestane can be decreased when it is combined with Primidone.
Promestriene
The therapeutic efficacy of Exemestane can be decreased when used in combination with Promestriene.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Exemestane.
Quinestrol
The therapeutic efficacy of Exemestane can be decreased when used in combination with Quinestrol.
Ranolazine
The metabolism of Exemestane can be decreased when combined with Ranolazine.
Rifabutin
The serum concentration of Exemestane can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Exemestane can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Exemestane can be decreased when it is combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Exemestane.
Rucaparib
The metabolism of Exemestane can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Exemestane can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Exemestane can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Exemestane can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Exemestane.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Exemestane.
Sildenafil
The metabolism of Exemestane can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Exemestane can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Exemestane can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Exemestane can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Exemestane can be decreased when combined with Sulfisoxazole.
synthetic conjugated estrogens, A
The therapeutic efficacy of Exemestane can be decreased when used in combination with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The therapeutic efficacy of Exemestane can be decreased when used in combination with Synthetic Conjugated Estrogens, B.
Telaprevir
The metabolism of Exemestane can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Exemestane can be decreased when combined with Telithromycin.
Tibolone
The therapeutic efficacy of Exemestane can be decreased when used in combination with Tibolone.
Ticlopidine
The metabolism of Exemestane can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Exemestane can be decreased when it is combined with Tocilizumab.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Exemestane.
Vemurafenib
The serum concentration of Exemestane can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Exemestane can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Exemestane can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Exemestane can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Exemestane can be decreased when combined with Ziprasidone.
